SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Noven Pharmaceuticals (NOVN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kendall harmon who wrote (55)11/16/1999 12:31:00 AM
From: Sr K  Read Replies (1) of 66
 
This is a test of using fixed font. June 30, 1999 December 31, 1998
(UNAUDITED) (AUDITED)
-------- --------
<S> <C> <C>
ASSETS
Current Assets:
Cash and cash equivalents $ 7,293 $ 5,573
Accounts receivable (less allowance for doubtful accounts
of $168 in 1999 and $268 in 1998) 4,201 3,044
Due from Vivelle Ventures LLC 3,284 3,489
Inventories 2,934 2,733
Prepaid and other current assets 350 421
-------- --------

18,062 15,260
Property, Plant and Equipment:
Property, plant and equipment, at cost 20,887 20,376
Less: accumulated depreciation and amortization 5,544 4,859
-------- --------

15,343 15,517
Other Assets:
Investment in Vivelle Ventures LLC 6,878 7,500
Patent development costs, net 1,816 1,765
Deposits and other assets 421 114
-------- --------

9,115 9,379
-------- --------

$ 42,520 $ 40,156
======== ========
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext